List of bibliographic references indexed by inhibition
Number of relevant bibliographic references: 286.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000085 (2020) |
Ran Li ; Kunchi Zhao ; Qing Ruan ; Chunyang Meng ; Fei Yin | The transcription factor Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2 |
| 000092 (2020) |
Camilla Br Dsgaard Nielsen [Danemark] ; Christian Nielsen [Danemark] ; Mads Nybo [Danemark] ; S Ren Andreas Just [Danemark] ; Pernille Just Vinholt [Danemark] | The in vitro effect of antirheumatic drugs on platelet function. |
| 000141 (2020) |
Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada] | Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature. |
| 000193 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000268 (2020) |
Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine] | NK Cell-Based Immune Checkpoint Inhibition |
| 000277 (2020) |
Sergiu Pasca [Roumanie] ; Ancuta Jurj [Roumanie] ; Bobe Petrushev [Roumanie] ; Ciprian Tomuleasa [Roumanie] ; Daniela Matei [Roumanie] | MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases |
| 000305 (2020) |
Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis] | Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation |
| 000320 (2020) |
Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. Grandis | Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance |
| 000327 (2020) |
Jakob Einhaus [Allemagne] ; Ann-Christin Pecher [Allemagne] ; Elisa Asteriti [Allemagne] ; Hannes Schmid [Allemagne] ; Kathy-Ann Secker [Allemagne] ; Silke Duerr-Stoerzer [Allemagne] ; Hildegard Keppeler [Allemagne] ; Reinhild Klein [Allemagne] ; Corina Schneidawind [Allemagne] ; Joerg Henes [Allemagne] ; Dominik Schneidawind [Allemagne] | Inhibition of effector B cells by ibrutinib in systemic sclerosis |
| 000331 (2020) |
Anne Y. Liu [États-Unis] | Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. |
| 000462 (2020) |
Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert Rübben | Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer |
| 000598 (2020) |
Angelo Fassio [Italie] ; Giovanni Adami [Italie] ; Alessandro Giollo [Italie] ; Ombretta Viapiana [Italie] ; Nazzarena Malavolta [Italie] ; Gianantonio Saviola [Italie] ; Roberto Bortolotti [Italie] ; Luca Idolazzi [Italie] ; Francesco Bertoldo [Italie] ; Maurizio Rossini [Italie] ; Davide Gatti [Italie] | Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study. |
| 000599 (2020) |
Giovanni Cagnotto [Suède] ; Minna Willim [Suède] ; Jan- Ke Nilsson [Suède] ; Michele Compagno [Suède] ; Lennart T. H. Jacobsson [Suède] ; Saedis Saevarsdottir [Suède] ; Carl Turesson [Suède] | Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register |
| 000631 (2019) |
P M Villiger [Suisse] | [Large-vessel vasculitis-giant cell and Takayasu arteritis]. |
| 000642 (2019) |
Francesca Salamanna ; Veronica Borsari ; Deyanira Contartese ; Viviana Costa ; Gianluca Giavaresi ; Milena Fini | What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence |
| 000661 (2019) |
Martina Biggioggero [Italie] ; Andrea Becciolini [Italie] ; Chiara Crotti [Italie] ; Elena Agape [Italie] ; Ennio Giulio Favalli [Italie] | Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis |
| 000700 (2019) |
Martin Krusche [Allemagne] ; Nikolas Ruffer [Allemagne] ; Ina Kötter [Allemagne] | Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature. |
| 000739 (2019) |
Niklas Prenissl [Allemagne] ; Juliane Lokau [Allemagne] ; Stefan Rose-John [Allemagne] ; Johannes Haybaeck [Autriche] ; Christoph Garbers [Allemagne] | Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage. |
| 000771 (2019) |
Eijiro Jimi [Japon] ; Nana Takakura ; Fumitaka Hiura ; Ichiro Nakamura ; Shizu Hirata-Tsuchiya | The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”? |
| 000806 (2019) |
Baodi Ren [République populaire de Chine] ; Jiayu Liu [République populaire de Chine] ; Kunyi Wu [République populaire de Chine] ; Junli Zhang [République populaire de Chine] ; Yanyan Lv [République populaire de Chine] ; Suzhi Wang [République populaire de Chine] ; Liping Liu [République populaire de Chine] ; Dan Liu [République populaire de Chine] | TNF-α-elicited miR-29b potentiates resistance to apoptosis in peripheral blood monocytes from patients with rheumatoid arthritis. |
| 000809 (2019) |
Piercarlo Sarzi-Puttini [Italie] ; Angela Ceribelli [Italie] ; Daniela Marotto [Italie] ; Alberto Batticciotto [Italie] ; Fabiola Atzeni [Italie] | Systemic rheumatic diseases: From biological agents to small molecules. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "inhibition"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "inhibition" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= inhibition
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
